We have shown that several isoforms of triadin, a protein involved in calcium release process through the ryanodine receptor, are expressed in rat skeletal muscle, and we have cloned two of these isoforms. One is the rat homolog of the 95-kDa triadin identified in rabbit skeletal muscle, and the second one, shorter, is a truncated form of the previous one, but with a new unique COOH-terminal end. We propose to name the two proteins identified here Trisk 95 and Trisk 51. We have produced antibodies specific to each isoform. Using these antibodies, we have shown that the newly identified protein, Trisk 51, is actually expressed in adult rat skeletal muscle and also in rat embryo skeletal muscle. 
We have shown that several isoforms of triadin, a protein involved in calcium release process through the ryanodine receptor, are expressed in rat skeletal muscle, and we have cloned two of these isoforms. One is the rat homolog of the 95-kDa triadin identified in rabbit skeletal muscle, and the second one, shorter, is a truncated form of the previous one, but with a new unique COOH-terminal end. We propose to name the two proteins identified here Trisk 95 and Trisk 51. We have produced antibodies specific to each isoform. Using these antibodies, we have shown that the newly identified protein, Trisk 51, is actually expressed in adult rat skeletal muscle and also in rat embryo skeletal muscle. Immunofluorescent labeling of rat skeletal muscle with anti-Trisk 95, anti-Trisk 51, or anti-ryanodine receptor antibodies shows a similar localization of these proteins, in the tissue. Transfection of L6 cells with cDNA of Trisk 51 or Trisk 95 leads to the expression of proteins with the expected molecular weight, identical to those detected in rat skeletal muscle. Both proteins appear during differentiation of satellite cells in myotubes which may indicate the involvement of these two isoforms in the building of a functional calcium release machinery.
The mechanism coupling excitation of the muscle cell to its contraction (E-C coupling) 1 is still an intense field of research. Two proteins have been identified which play a crucial role in E-C coupling: the dihydropyridine receptor and the ryanodine receptor (RyR) (1) . The dihydropyridine receptor is a voltagedependent L-type calcium channel localized in the T-tubule membrane and is the sensor of its depolarization (2, 3) . RyR is a calcium channel localized in the terminal cisternae of the sarcoplasmic reticulum which facilitates the massive release of calcium from the sarcoplasmic reticulum (4 -6) and the resulting muscle contraction. Different proteins located specifically in the triad of skeletal muscle are thought to be involved in the E-C coupling process with triadin being among these. This 95-kDa glycoprotein has first been identified in rabbit skeletal muscle (7, 8) and has been named triadin because of its specific localization in the triad membrane (9, 10) . Although several transcripts of triadin were detected in rabbit skeletal muscle (11) , only one skeletal isoform has been cloned (12) . Three isoforms of triadin have first been cloned in rabbit cardiac muscle (13) , but only two have been cloned recently in canine cardiac muscle (14) . The exact function of triadin is unknown. Triadin was first imagined to connect the dihydropyridine receptor and RyR (7, 8) , but the structure of the protein and its membrane topology make this very unlikely (12, 15) . A trimolecular interaction has been shown among triadin, RyR, and calsequestrin, the protein that traps Ca 2ϩ in the reticulum (16) . This complex has been shown in cardiac muscle (13, 17) as well as in skeletal muscle (18, 19) . Another protein, junctin (20) , has also been involved in this interaction (17) , thus forming a quaternary complex. The hypothesis that triadin maintains the triad architecture has been proposed recently (21) based on its ability to form large aggregates. In addition to a structural or mechanical function of triadin, its implication in a regulatory mechanism for the calcium release process is being researched. The interaction between RyR and triadin has been shown to be functional because skeletal triadin is able to inhibit RyR calcium channel activity (22, 23) .
In the present work we show that multiple isoforms of triadin are expressed in rat skeletal muscle, and we have cloned two of these. One is the rat homolog of the rabbit skeletal muscle identified by Knudson et al. (12) . The other is a shorter version of the first. We propose to name the two proteins identified here Trisk 95 and Trisk 51, according to their apparent molecular mass. We have produced antibodies specific to each isoform, and we have used them to characterize the cellular localization, the biochemical behavior of both isoforms, and their evolution in the first differentiation steps of skeletal muscle cells in primary culture. We have expressed these two isoforms in a myogenic cell line. This work is the first evidence of a second isoform of triadin in skeletal muscle and raises the question of the specific role of each isoform.
EXPERIMENTAL PROCEDURES
cDNA Cloning-We built an oligo(dT)-primed, size-selected cDNA library from rat skeletal muscle mRNA in Ziplox using the Superscript choice system for cDNA synthesis kit (Life Technologies, Inc., Cergy Pontoise, France). Packaging was performed using Gigapack III Gold packaging extract (Stratagene). This library was screened with a 32 P probe corresponding to nucleotides 114 -834 (BglII-NcoI) of rabbit skeletal muscle triadin, obtained by reverse transcriptase-PCR amplification on rabbit skeletal muscle mRNA, and we isolated 42 positive clones. Two positive clones (named 2B and 2U) were automatically sequenced (Génôme Express, Grenoble, France) and are presented here. Most of the other positive clones isolated from our cDNA library correspond to part of trisk 51 or trisk 95.
mRNA Purification and Northern Blot-Total RNA was extracted from adult or embryonic (fetal day 20) rat skeletal muscle, from rabbit * This work was supported in part by grants from the Association Française contre les Myopathies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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‡ To whom correspondence should be addressed. Tel.: 33-4-7688-5706; Fax: 33-4-7688-5487; E-mail: imarty@cea.fr. 1 The abbreviations used are: E-C, excitation-contraction; RyR, ryanodine receptor; PCR, polymerase chain reaction; PBS, phosphate-buffered saline; bp, base pair(s); kb, kilobases; A-T95, antibodies against Trisk 95; A-T51, antibodies against Trisk 51; A-Nter, antibodies against the NH 2 -terminal peptide.
skeletal muscle, and from rat kidney, using RNA-Plus (Quantum Bioprobe, Montreuil, France). The mRNA was purified twice using the Oligotex mRNA purification system (Qiagen SA, Courtaboeuf, France).
For Northern blot analysis, mRNA (3 g/lane) was electrophoresed through 1% agarose and 0.8% formaldehyde denaturating gel. After transfer to a nylon membrane (GeneScreen Plus, NEN Life Science Products, Paris, France), the blot was hybridized using ExpressHyb hybridization solution (CLONTECH) and a 32 P-labeled probe corresponding to nucleotides Ϫ86 to ϩ335 of clone 2B. The blot was washed three times for 15 min each at room temperature with 2 ϫ SSC and 0.1% SDS (1 ϫ SSC ϭ 0.15 M NaCl and 0.015 M sodium citrate) and exposed to Hyperfilm ␤-Max (Amersham Pharmacia Biotech, Les Ulis, France) for 16 h at Ϫ70°C.
Reverse Transcriptase-PCR-Reverse transcriptase-PCR was performed on 100 ng of purified rat skeletal muscle mRNA using the One step reverse transcriptase-PCR system (Life Technologies, Inc.). The sense primer corresponds to the first 28 coding nucleotides of clone 2B (5Ј-ATGACTGAGATCACAGCTGAAGGAAATG-3Ј) and the antisense primer to nucleotides 1369 -1396 of clone 2U (5Ј-GTTGTGGCTGTGG-TAGTTTAGGCT TTAC-3Ј). After an initial denaturation, reverse transcription was performed for 30 min at 50°C. After a denaturation step (2 min at 94°C), 40 PCR cycles were performed (each cycle is composed of 45 s at 94°C, 30 s at 55°C, and 2 min at 72°C), with a final elongation step of 10 min at 72°C. The PCR product was electrophoresed on 1% agarose gel and contained only one amplified fragment, which was electroeluted and sequenced.
Microsomes-Adult rat skeletal muscle (0.5-1 g) was collected from the hind legs. Crude microsomes were prepared as described previously for rat cardiac muscle (24) . Briefly, after homogenization of the muscle in 30 ml of 200 mM sucrose, 20 mM HEPES (pH 7.4), 0.4 mM CaCl 2 , 2 mM leupeptine, 100 mM phenylmethylsulfonyl fluoride, and 1 mM diisopropyl fluorophosphate, the low speed pellet (30 min at 2500 ϫ g) was discarded, and the microsomes were obtained after a 50-min centrifugation at 41,000 ϫ g. They were homogenized at 4 -8 mg/ml in 0.1 M NaCl, 30 mM imidazole (pH 6.8), 8% sucrose, protease inhibitors, and stored in liquid nitrogen. Embryonic skeletal muscle was collected from hind limbs at fetal day 20, and crude microsomes were prepared identically.
Antibodies-The peptide synthesis, the coupling to ovalbumin, and the immunization of the rabbits were performed as described previously for the peptide corresponding to the NH 2 -terminal end (amino acids 1-16) of rabbit skeletal muscle triadin (15) leading to the A-Nter antibodies used in this study.
The COOH-terminal peptide of Trisk 51 corresponds to amino acids 451-461 of Trisk 51, with an extra Tyr added at its NH 2 -terminal end to allow coupling to ovalbumin (Tyr-Glu-Gln-Gly-Lys-Lys-Lys-SerGlu-Ala-Gly), and the COOH-terminal peptide of Trisk 95 to amino acids 673-687 of Trisk 95, with an extra Tyr on the NH 2 -terminal end of the peptide (Tyr-Asn-Pro-Gly-Lys-Ser-Asn-Ser-Pro-Gly-Gln-Lys-GlnGln-Glu-Gln).
Anti-ryanodine receptor antibodies (A-RyR), obtained by immunization of a rabbit with RyR purified from pig skeletal muscle, were described previously (25) .
Western Blot-The presence of Trisk 51 or Trisk 95 in different samples was assayed by Western blot (26) . The proteins were loaded on an 8.5% polyacrylamide gel. After electrophoretic separation, the proteins were transferred to an Immobilon P sheet (Millipore, Bedford, MA) for 2 h at 1 A. After 30 min at room temperature in PBS, 0.1% Tween 20, and 4% non-fat dry milk (Bio-Rad), the membranes were incubated for 3 h at room temperature with primary antibodies diluted at 1:20,000 in the same buffer. For detection, membranes were incubated with a 1:10,000 diluted goat horseradish peroxidase-conjugated anti-rabbit IgG (BIOSOURCE International) overnight at 4°C. After incubation with a chemiluminescence reagent (Renaissance, NEN), the membranes were exposed to x-ray films (Hyperfilm ␤-Max).
Cell Cultures and Transfection-Rat myogenic L6 cells (27) were obtained from the European Collection of Animal Cell Cultures ECACC (clone C5) and were cultured in Dulbecco's modified Eagle's medium supplemented with 15% fetal bovine serum (Life Technologies, Inc.) and 1% penicillin-streptomycin. They were transfected with LipofectAMINE Plus Reagent (Life Technologies, Inc.) in a 10-cm plate with 6 g of plasmid/plate. The expression plasmid used for transfection was plasmid pcDNA3.1 (Invitrogen), with the cDNA coding for Trisk 51 (full-length sequence of clone 2B) or Trisk 95 (coding region) inserted in the EcoRI restriction site. Transfection was performed during 5 h at 37°C in Dulbecco's modified Eagle's medium. The cells were collected 48 h after transfection. They were scraped into 15 mM NaCl, 1 mM EDTA, 200 M phenylmethylsulfonyl fluoride, 2 mM diisopropyl fluorophosphate.
Satellite Cell Culture-Primary cultures of rat skeletal muscle cells from satellite cells were obtained by trypsinization of muscle pieces of 20-day-old rat embryos (28) . Briefly, the skeletal muscle was collected from the hind limbs of the embryos, cut in small pieces, and trypsinized 30 min at 37°C. After filtration, the cells were collected by centrifugation and seeded at 1-3.10 6 cells/ml in Dulbecco's modified Eagle's medium supplemented with 15% fetal bovine serum, 2% penicillin-streptomycin, 2% Nystatin. When the cells were confluent (approximately 24 h after seeding), differentiation was induced by changing the culture medium for Dulbecco's modified Eagle's medium supplemented with 10% horse serum and 1% penicillin-streptomycin. The differentiation days are counted from this medium change. The cells were collected either at this moment (day 0) or after 2 days or 5 days in differentiation medium, in the same way as L6 cells.
Immunofluorescence Microscopy-Adult rat skeletal muscle fibers were fixed with 4% paraformaldehyde in PBS at 4°C overnight. After fixation, tissues were incubated in 10% then 20% sucrose in PBS (twice for 2 h) for cryoprotection, embedded in Tissue-Tek O.C.T. compound (Miles Inc.), frozen, and stored at Ϫ20°C. Cryosections (10-m thickness) collected on microscope slides were permeabilized with 0.25% Triton X-100 in PBS, incubated for 2 h at room temperature with primary antibodies diluted 1:200 in PBS supplemented with 0.1% Triton X-100, 0.5% bovine serum albumin, and 2% goat serum, and washed three times for 10 min each at 4°C with PBS and 0.1% Triton X-100. The sections were then incubated with indocarbocyanine-labeled goat anti-rabbit IgG Fab fragment (Jackson Immunoresearch Laboratory Inc.) (1:1500) for 1 h at room temperature. After three washes in PBS (10 min each), the nuclei were stained with 1 g/ml Hoechst 33258 in PBS, and the samples were mounted with antifading solution and examined with a microscope equipped with fluorescence optics. To assess the specificity of the antibodies, samples were incubated according to the same protocol but without primary antibodies (control).
For myotubes (satellite cells after 2 days of differentiation), the immunolabeling was performed directly in the culture plate. After fixation of the cells with 4% paraformaldehyde for 15 min and 2 ϫ 5-min washes with PBS, the cells were permeabilized for 5 min with PBS and 0.25% Triton X-100, and the immunolabeling was achieved as described for muscle sections.
Deglycosylation-The samples were first denaturated for 2 min at 100°C in 50 mM Tris (pH 7.4), 5% ␤-mercaptoethanol, 0.5% SDS. Deglycosylation was then achieved for 16 h at 37°C in 80 mM Tris (pH 7.4), 30 mM EDTA, 1.2% Triton X-100, 2% ␤-mercaptoethanol, 0.2% SDS, 1 mM phenylmethylsulfonyl fluoride, with 1 unit of N-glycosidase F (Roche Diagnostics, Meylan, France) for 50 g of proteins. Control samples were incubated in the same conditions, without enzyme. The samples were then analyzed by Western blot.
RESULTS
cDNA Cloning-We built an (oligo)dT-primed cDNA library from rat skeletal muscle mRNA. We screened this library with a probe corresponding to nucleotides 114 -834 of rabbit skeletal muscle triadin (12) . One of the positive clones, clone 2B, 2263 bp, contains an open reading frame of 1386 bp and corresponds to a protein of 461 amino acids (51.3 kDa). This clone possesses 86 bp in the 5Ј-untranslated region, upstream of the initial ATG. The poly(A) tail starts at nucleotide 2177 with a polyadenylation signal 24 bp upstream of the poly(A). The corresponding protein, named Trisk 51 (for TRIadin, SKeletal muscle, 51 kDa), is shorter than the triadin described in rabbit skeletal muscle (12) and is homologous on the common part (Fig. 1) . Another clone, clone 2U, 3542 bp, corresponds to part of a longer protein, potentially the rat homolog of the rabbit skeletal 95-kDa triadin. The 5Ј-coding region was absent in this clone. It contains a poly(A) tail and a polyadenylation signal 22 bp upstream of the poly(A). Using antibodies directed against the NH 2 -terminal end (first 16 amino acids) of rabbit skeletal muscle triadin (15), we showed that the NH 2 -terminal end of the rat skeletal homologous protein cross-reacts with these antibodies, indicating that these amino acids are well conserved among rabbit triadin and the two isoforms of rat skeletal muscle triadin. Because the two isoforms of rat have a common NH 2 -terminal end, we used a sense primer corresponding to the first 28 coding nucleotides of clone 2B and an antisense primer in a region specific to clone 2U ( Fig. 2A) , designed to amplify a 1396-bp fragment. We obtained the 5Ј-coding region of clone 2U by reverse transcriptase-PCR on rat skeletal muscle mRNA, and we built a complete clone for this protein as illustrated in Fig. 2 by ligation of this 1396-bp PCR fragment and part of clone 2U, using an internal restriction site. This full-length sequence (4241 bp), with an open reading frame of 2061 bp, corresponds to a protein of 687 amino acids and a molecular mass of 77,200 Da. It is the rat equivalent of the rabbit skeletal muscle triadin identified by Knudson et al. (12) , and it migrates in an acrylamide gel with an apparent molecular mass of 95 kDa. We propose to name it Trisk 95 (for TRIadin, SKeletal muscle, 95 kDa). Fig. 1 presents the amino acid sequence alignments between rabbit skeletal muscle triadin and rat triadins. Trisk 51 is identical to Trisk 95 except for amino acids 95 and 143 and for its last six COOH-terminal amino acids.
Multiple Isoforms of Triadin Are Expressed in Rat Skeletal Muscle-We analyzed by Northern blot the presence of multiple mRNAs corresponding to triadin in rat skeletal muscle, as observed previously in rabbit skeletal muscle (11) . Using a probe corresponding to the 5Ј-end of clone 2B, we identified the presence of multiple transcripts of triadin (Fig. 3) . We observed at least six transcripts in adult rat skeletal muscle (lane 2), at approximately 1.35, 2.5, 3.4, 4.4, 6.5, and 7.5 kb.
According to the size of the full-length cDNA, Trisk 51 (clone 2B) could correspond to the transcript at 2. COOH-terminal end of Trisk 95, these two parts being specific to each isoform. We have also previously raised antibodies against the NH 2 -terminal end of rabbit skeletal muscle triadin (15) , which is well conserved (see Fig. 1 ) between the isoforms of rat triadin presented here and the rabbit triadin identified previously (12) . Antibodies directed against Trisk 95 (A-T95) are expected to react only with a protein of 95 kDa, antibodies directed against Trisk 51 (A-T51) are expected to react only against a protein of 51 kDa, whereas antibodies directed against the NH 2 -terminal peptide (A-Nter) are expected to cross-react with both. This is precisely the result presented in Fig. 4 . We can observe the presence in rat skeletal muscle of a protein of 51 kDa, corresponding to the sequence of clone 2B, which is reactive with our antibodies against the COOH-terminal deduced sequence for Trisk 51 (lane 7). This is the first evidence for a new isoform of triadin in skeletal muscle. In addition, we can observe, as expected, that this protein is also reactive with A-Nter antibodies (lane 2). A-Nter antibodies recognized at least two proteins in rat skeletal muscle (lane 2): one at 95 kDa (Trisk 95) and one at 51 kDa (Trisk 51). This is not specific to the species because the two same proteins (or their homologs) are also observed in rabbit skeletal muscle (lane 1). Trisk 51 is expressed early in rat development because it can be observed in embryonic rat skeletal muscle (embryos of 20 days; lane 8). This is also the case for Trisk 95 (lane 5). Although the NH 2 -terminal end is conserved between rabbit and rat triadin, the COOH-terminal end is not, and neither AT95 (lane 3) nor AT51 (lane 6) cross-reacts with the rabbit equivalent. In addition, antibodies directed against the COOHterminal end of 95-kDa rabbit skeletal muscle triadin (15) do not react with the equivalent rat Trisk 95 (not shown). As shown in Fig. 1 , the modifications between the COOH-terminal end of rabbit and 95-kDa rat triadin concerned mainly prolines (in addition to the adjunction of three more amino acids in rat). This is probably enough to induce a difference in the structure of both COOH-terminal ends and to explain the absence of cross-reactivity of the antibodies.
Cellular Expression-We have cloned the two cDNAs corresponding to Trisk 51 and Trisk 95 in a mammalian expression plasmid (pcDNA3.1) and transfected a rat skeletal muscle cell line (L6 cells) with either of these plasmids. The protein content was analyzed by Western blot 48 h after transfection, and the result is presented in Fig. 5 .
Cells transfected with the cDNA of Trisk 95 present a band at approximately 95 kDa, identical to that found in rat skeletal muscle (Fig. 5, lanes 1) , reactive with anti-NH 2 -terminal antibodies (Fig. 5A, lane 2) , and anti-Trisk 95 (Fig. 5B, lane 2) , as expected. In the same way, cells transfected with the cDNA of Trisk 51 present a band at approximately 51 kDa, identical to the one present in rat skeletal muscle (Fig. 5, lanes 1) and reactive with A-Nter (Fig. 5A, lane 4) and A-Trisk 51 (Fig. 5D,  lane 4) . When the cells are transfected with the plasmid alone, no signal is observed with either of these antibodies (Fig. 5,  lanes 3 ). This indicates in addition that neither of these two proteins is expressed in proliferating L6 cells. The cDNA isolated for Trisk 51 clearly corresponds to a protein of 51 kDa and the cDNA of Trisk 95 to a protein with an apparent molecular mass of 95 kDa.
Trisk 95 as well as Trisk 51 is present as a double band. The doublet of Trisk 51 is more noticeable and could be identical to the one observed in embryonic rat skeletal muscle (Fig. 4, lane  8) . These double bands could not result from a proteolytic degradation because the samples were prepared in the presence of protease inhibitors, and the two bands reacted at the same time with antibodies directed against the NH 2 -terminal and the COOH-terminal end of the protein. They could be potentially the result of an incomplete post-translational modification.
The signal observed with either of these antibodies (A-T95 and A-T51) is specific, as it can be abolished by preincubation of the antibodies with the corresponding immunogenic peptide (Fig. 5, C and D) . In these conditions, the signal is abolished on the two bands.
Glycosylation of Expressed Trisk 95 and Trisk 51-To determine if the migration of Trisk 95 and Trisk 51 as a double band in transfected cells could be caused by incomplete glycosylation of the protein, we tried to deglycosylate either Trisk 51 or Trisk 95 using N-glycosidase F. After deglycosylation, the proteins were analyzed by Western blot. The result is presented on Fig.  6 . Glycosidase F induced a shift in the migration of both bands of Trisk 95, which appeared as a single band of slightly lower molecular mass (lanes 2 and 3) , and the two bands of Trisk 51 were reduced to the lower band (lanes 5 and 6) . This indicates that Trisk 95 is glycosylated, as the 95-kDa triadin of rabbit skeletal muscle (10) , and that Trisk 51 is also glycosylated. There are five potential N-glycosylation sites (Asn-X-Ser/Thr) on Trisk 95 and only three on Trisk 51. Both proteins could be glycosylated either on the same asparagines or on different ones. Indeed, it has been proposed that the 95-kDa rabbit triadin is glycosylated on asparagine 625, which is the equiv- Western blot analysis with A-Nter, A-T95, or A-T51 . The reactivity of antibodies directed against the NH 2 -terminal end of rabbit triadin (A-Nter), the COOH-terminal end of Trisk 95 (A-T95), or the COOH-terminal end of Trisk 51 (A-T51) was tested on rabbit skeletal muscle microsomes (5 g/lane, lanes 1, 3, and 6 ), on rat skeletal muscle microsomes (5 g/lane, lanes 2, 4, and 7) , or on rat embryo skeletal muscle microsomes (30 g/lane, lanes 5 and 8) .
FIG. 4.
alent of asparagine 592 in Trisk 95 and which is absent in Trisk 51. Because the sequence of the two proteins is well conserved, and both are glycosylated when expressed in L6 cells, it is more probable that they were both glycosylated on the same asparagines. In these cells, Trisk 95 has probably several glycosylations, one on asparagine 592 and an additional one on another asparagine that is common with Trisk 51.
Immunofluorescent Labeling of Rat Skeletal Muscle-Sections of adult rat skeletal muscle were fixed, permeabilized, labeled with anti-Trisk 95, anti-Trisk 51, or anti-RyR followed by an incubation with indocarbocyanine-labeled secondary antibodies (Fig. 7) . The same staining (a double row of dots), was observed with anti-Trisk 95, anti-Trisk 51, and anti-RyR. This suggests that Trisk 95 and Trisk 51 could have a similar localization in the triad of skeletal muscle.
Expression of Trisk 51 and Trisk 95 in in Vitro Developing
Myotubes-Satellite cells from rat embryonic skeletal muscle were cultured in vitro and induced in myotube differentiation. The presence of Trisk 51 and Trisk 95 was determined either by Western blot at different differentiation stages (0, 2, or 5 days in differentiation medium; Fig. 8 ) or by immunocytolabeling on 2-day-old myotubes ( Fig. 9 ). Fig. 8 shows that both isoforms of triadin are absent in proliferating satellite cells (0 day in differentiation medium, lanes 2 and 6). However, both appear as differentiation takes place (Fig. 8, lanes 3 and 4 for Trisk 51; lanes 7 and 8 for Trisk 95; respectively 2 and 5 days of differentiation). Trisk 51 always appears as a doublet at 51 kDa (slightly visible at day 2, lane 3, and more noticeable at day 5).
After 2 days of differentiation, myotubes are observed in the culture plate, and after 5 days they are very numerous and show spontaneous contractions. 2-day-old myotubes were fixed with paraformaldehyde, permeabilized with detergent, and immunolabeled with anti-Trisk 51, anti-Trisk 95, or anti-RyR (Fig. 9) as was performed for sections of adult rat skeletal muscle. The nuclei of the cells, represented on the lower panels (Fig. 9, b, d, f, and h) , show the location of the myotubes, characterized by the alignment of the nuclei, among all of the other cells. The upper panels (Fig. 9, a, c, e, and g) show that among all the cells, only the myotubes are labeled with the antibodies. The young myotubes are all strongly stained with the three antibodies, indicating a high level of expression of these proteins as soon as 2 days after the beginning of differentiation. The signal obtained with anti-peptide antibodies was abolished by a preincubation of the antibodies with the corresponding peptide (not shown). DISCUSSION We have shown that at least six transcripts of triadin are present in rat skeletal muscle, and we have cloned two of them. The two corresponding proteins are named Trisk 51 and Trisk 95. Trisk 95 is the rat equivalent of the 95-kDa rabbit triadin, identified in skeletal muscle, and considered up to now to be the only triadin present in skeletal muscle. With the identification of several isoforms of triadin, skeletal muscle resembles cardiac muscle, in which three isoforms of triadin have first been cloned (13) . These three isoforms of cardiac triadin were of different sizes (35, 40, and 92 kDa), and they were identical in their NH 2 -terminal sequences (up to residue 264), whereas the COOH-terminal sequences differed from each other. More recently, in canine cardiac muscle only two isoforms of triadin have been cloned (14) , and it has been shown that the 40-kDa protein is a glycosylated form of the 35-kDa triadin. Triadin has been shown to interact with junctin and RyR in cardiac muscle, and it is the shortest isoform CT1 (35 kDa) which appears to be responsible for this interaction (17) . Many studies were conducted concerning the interaction of skeletal muscle triadin with other proteins of the triad in an attempt to understand the role of triadin (18, 19, 22, 23) . Under these conditions, the identification of multiple isoforms of triadin is of utmost importance because different functions could be associated with different isoforms.
The two isoforms of rat skeletal muscle triadin identified here are composed of 461 amino acids (Trisk 51) and 687 amino acids (Trisk 95). Trisk 51 is shorter, almost identical to Trisk 95, except for residues 95 and 143 and the 6 last COOHterminal amino acids of Trisk 51. The isoforms of triadin in skeletal muscle could, in their internal homologies, behave in a manner similar to the cardiac ones. In this new context, all of the studies performed to identify the proteins that interact with triadin using peptides or fusion proteins corresponding to parts of triadin have to be reconsidered. Depending upon the localization of these peptides/fusion proteins (NH 2 -terminal, COOH-terminal . . . ) corresponding to either a common sequence or a specific sequence, the results are related either to all of the isoforms (22, 23, NH 2 -terminal peptides) or to only a subset of these isoforms (18, 19) .
We have shown by Western blot that Trisk 51 is definitely present as a protein in rat skeletal muscle. We give the first evidence of the presence of a new isoform of triadin in skeletal muscle. This protein was in fact observed previously by our group and other groups working on rabbit skeletal muscle triadin. However, it was believed to be a proteolytic degradation of the 95-kDa triadin (12, 15, 29) . We show, in addition, that this protein is already present in rat embryos (fetal day 20). We transfected a myogenic cell line (L6 cells, rat skeletal muscle) with either trisk 51 or trisk 95, and we showed that this transfection leads to the appearance of proteins with the expected molecular mass. Both proteins appeared as a double band when expressed in L6 cells, and we demonstrate that this is caused by an incomplete glycosylation of the expressed protein. In addition, we show that in rat embryonic skeletal muscle or in primary cultured myotubes Trisk 51 appears also as a double band.
We have compared the cellular organization of Trisk 51, Trisk 95, and RyR in sections of adult rat skeletal muscle. We observed that Trisk 51 behaves as Trisk 95 and RyR. We have studied the expression of Trisk 51 and Trisk 95 during the in vitro differentiation of primary rat skeletal muscle cells, and we have shown that both triadin isoforms appear as differentiation takes place. Furthermore, using immunocytolabeling, we have shown that both proteins are expressed strongly in young myotubes.
We observed, by Northern blot hybridization, that all of the isoforms of triadin are not expressed identically between rat adults and embryos. The major transcript in adult muscle migrates at 4.4 kb (Trisk 95) and, in decreasing order of abundance, we observed transcripts at 6.5 and 3.3 kb, then 2.5 kb (Trisk 51), and in lower amounts at 1.35 and 7.5 kb. The situation in rat embryos (perinatal, fetal day 20) is quite different, as the two major transcripts are observed at 4.5 and 3.3 kb, with almost equivalent amounts of each. This indicates that the relative amount of Trisk 95 compared with the other isoforms is lower in embryonic muscle than in adult muscle. The same phenomenon was observed with the two isoforms ␣ and ␤ of RyR in chicken skeletal muscle, their relative abundance depending upon the development stage (30) . Trisk 95 could then have a function more specifically dedicated to the adult function of the muscle. Trisk 95 could be involved in calcium release for the muscle contraction, a function not yet totally developed in embryonic muscle, as observed from the lack of expression in the early stages of development of RyR1 and ␣1 S -dihydropyridine receptor, the two skeletal isoforms of the calcium channels involved in E-C coupling of adult skeletal muscle (31, 32) . In cardiac muscle, the longer isoform of triadin CT3 has been shown to be expressed in lower amounts than the shorter one, CT1 (14) . This is not the case in skeletal muscle, and both isoforms Trisk 95 and Trisk 51 seem to be present in similar amounts. Trisk 95 could then be involved specifically in a skeletal type of E-C coupling. On the contrary, the other isoforms (and particularly the protein corresponding to the transcript at 3.3 kb, not characterized in this work) could have a function more related to muscle development and could be associated with proteins other than the ones associated with Trisk 95 in adult tissue, or with different isoforms of the same proteins, but expressed at this precise developmental stage.
In conclusion, we have shown the presence of a new isoform of triadin in rat skeletal muscle. As it was proposed recently for canine cardiac triadin CT1 (14) , this isoform could have an important function in skeletal muscle. The characterization of this protein shows that it could be involved in the calcium release regulation for adult muscle contraction. In addition, the differential behavior of the Trisk isoforms during myogenic development suggests their possible involvement in developmental process.
